Gian Lifecare Ltd

GIANLIFE

Watchlist

AI Mode

‌

Market Cap

₹ 9 Cr

P/E

—

‌

Investment Checklist

How to read checklist?

Performance

UNDER PERFORMER

Valuation

REASONABLE

Growth

SLUGGISH

Profitability

LOW MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Gian Life Care Limited is primarily engaged in providing diagnostic and healthcare tests, operating major labs in Kanpur and Lucknow.

Established in 1995, Gian Pathology has evolved into a large diagnostic center under the leadership of Arun Kumar Gupta.

The company offers a wide range of approximately 1,344 diagnostic tests in multiple disciplines including molecular biology.

Gian Life Care expanded through an IPO, issuing over 1.4 million equity shares, raising Rs 3.11 Crore.

Plans are underway to set up more diagnostic labs across various regions, indicating growth ambitions.

Sector

Healthcare

Industry

Diagnostic Services

Market Cap

9 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

48.3

PEG Ratio

—

P/B Ratio

0.5

52W High

20.75

52W Low

8.28

Sales CAGR

-49.47%

-25.33%

-2.81%

10Y

—

Profit CAGR

-100.96%

-67.13%

-32.72%

10Y

—

ROE

TTM

-0.19%

10.44%

15.44%

10Y

—

ROCE

TTM

2.13%

14.60%

20.56%

10Y

—

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
INVICTA	88.00	111 Cr	23.59	2.17	0.00	35.97	39.64	0.00
ASPIRA	66.96	69 Cr	28.56	9.47	0.00	16.62	13.17	13.75
NIDAN	18.95	26 Cr	13.44	0.39	0.00	3.32	6.57	2.69
GIANLIFE	8.89	9 Cr	—	0.48	0.00	-0.19	2.13	-0.22
CTLLAB	39.50	9 Cr	25.99	1.02	0.00	5.19	7.65	4.22
DLCL	17.50	8 Cr	25.36	0.76	0.00	4.53	3.40	2.92
DOLPHMED	2.61	4 Cr	—	0.39	0.00	-0.26	-0.12	-0.16

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	1.55	2.43	2.30	3.79	4.60	1.98	1.95	1.59	1.11	0.87
Expenses	2.32	1.92	1.97	1.60	1.56	1.76	1.73	1.11	1.12	0.73
Operating Profit	-0.77	0.51	0.33	2.19	3.04	0.22	0.22	0.48	-0.01	0.14
OPM %	-49.68	20.99	14.35	57.78	66.09	11.11	11.28	30.19	-0.90	16.09
Other Income	0.18	0.14	0.15	0.19	0.18	0.19	0.17	0.16	-0.24	0.15
Interest	0.11	0.12	0.11	0.14	0.10	0.14	0.12	0.12	0.13	0.09
Depreciation	0.12	0.13	0.13	0.16	0.11	0.12	0.12	0.12	0.27	0.11
Profit Before Tax	-0.82	0.40	0.24	2.08	3.02	0.15	0.14	0.39	-0.65	0.08
Tax %	-15.85	35.00	16.67	25.48	29.47	40.00	21.43	10.26	7.69	37.50
Net Profit	-0.95	0.26	0.20	1.55	2.13	0.09	0.12	0.35	-0.60	0.05
EPS in Rs	-0.92	0.25	0.20	1.50	2.07	0.09	0.12	0.34	-0.59	0.05

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	16	12	13	6.63	5.52
Expenses	9.91	10	7.05	5.72	4.69
Operating Profit	6.02	1.82	6.07	0.91	0.83
OPM %	37.81	15.29	46.29	13.79	15.04
Other Income	0.51	0.69	0.67	0.26	0.24
Interest	0.35	0.43	0.46	0.51	0.46
Depreciation	0.33	0.50	0.53	0.63	0.62
Profit Before Tax	5.85	1.59	5.75	0.04	-0.04
Tax %	25.27	33.23	27.75	196.88	-100.00
Net Profit	4.37	1.06	4.15	-0.04	-0.08
EPS in Rs	—	1,36,50,811.60	4.02	-0.04	-0.08
Dividend Payout %	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	10	10	10	10
Reserves	3.69	4.78	8.93	8.89
Borrowings	1.87	4.58	4.88	5.84
Other Liabilities	7.17	8.55	8.48	11
Total Liabilities	23	28	33	36
Fixed Assets	3.50	4.62	5.07	4.45
CWIP	0.12	0.14	0.14	0.14
Investments	0.00	0.00	0.00	0.00
Other Assets	19	23	27	31
Total Assets	23	28	33	36

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	5.79	2.22	0.70	0.27
Cash from Investing Activity	-4.12	-0.94	-0.32	0.25
Cash from Financing Activity	0.67	-0.37	-0.16	0.45
Net Cash Flow	2.34	0.91	0.22	0.97

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	60.68%	56.90%	53.10%	53.10%	51.73%	48.47%	32.82%	31.99%	32.09%	32.09%	32.09%	32.09%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	0.01%
Public	39.32%	43.10%	46.90%	46.90%	48.27%	51.53%	67.18%	68.01%	67.90%	67.90%	67.90%	67.90%
Total Shareholders	526	1,089	1,336	2,098	2,092	2,426	3,349	3,863	4,298	4,382	4,363	4,285

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Mar 17, 2025	Tejesh hasmukh shah	Bulk	Buy	17.92	0.10 Cr	58,155	0.56
Feb 07, 2025	Harish kumar	Bulk	Buy	16.76	0.13 Cr	80,000	0.77
Nov 29, 2024	Arun kumar gupta	Bulk	Buy	19.66	0.13 Cr	65,217	0.63
Nov 28, 2024	Arun kumar gupta	Bulk	Sell	18.36	0.11 Cr	62,000	0.59
Nov 04, 2024	Arun kumar gupta	Bulk	Buy	22.20	0.16 Cr	70,000	0.67
Oct 31, 2024	Arun kumar gupta	Bulk	Sell	18.16	0.13 Cr	70,000	0.67
Sep 13, 2024	Gaurav manocha	Bulk	Buy	23.16	0.19 Cr	84,000	0.81
Sep 13, 2024	Tejesh hasmukh shah	Bulk	Buy	23.14	0.52 Cr	2,26,001	2.18
Sep 13, 2024	Sundiip devaadigaa	Bulk	Sell	23.11	0.69 Cr	2,97,805	2.87
Sep 04, 2024	Jainam share consultants pvt....	Bulk	Buy	22.79	0.23 Cr	1,00,000	0.96

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY22

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	1.55	2.43	2.30	3.79	4.60	1.98	1.95	1.59	1.11	0.87
Expenses	2.32	1.92	1.97	1.60	1.56	1.76	1.73	1.11	1.12	0.73
Operating Profit	-0.77	0.51	0.33	2.19	3.04	0.22	0.22	0.48	-0.01	0.14
OPM %	-49.68	20.99	14.35	57.78	66.09	11.11	11.28	30.19	-0.90	16.09
Other Income	0.18	0.14	0.15	0.19	0.18	0.19	0.17	0.16	-0.24	0.15
Interest	0.11	0.12	0.11	0.14	0.10	0.14	0.12	0.12	0.13	0.09
Depreciation	0.12	0.13	0.13	0.16	0.11	0.12	0.12	0.12	0.27	0.11
Profit Before Tax	-0.82	0.40	0.24	2.08	3.02	0.15	0.14	0.39	-0.65	0.08
Tax %	-15.85	35.00	16.67	25.48	29.47	40.00	21.43	10.26	7.69	37.50
Net Profit	-0.95	0.26	0.20	1.55	2.13	0.09	0.12	0.35	-0.60	0.05
EPS in Rs	-0.92	0.25	0.20	1.50	2.07	0.09	0.12	0.34	-0.59	0.05

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	16	12	13	6.63	5.52
Expenses	9.91	10	7.05	5.72	4.69
Operating Profit	6.02	1.82	6.07	0.91	0.83
OPM %	37.81	15.29	46.29	13.79	15.04
Other Income	0.51	0.69	0.67	0.26	0.24
Interest	0.35	0.43	0.46	0.51	0.46
Depreciation	0.33	0.50	0.53	0.63	0.62
Profit Before Tax	5.85	1.59	5.75	0.04	-0.04
Tax %	25.27	33.23	27.75	196.88	-100.00
Net Profit	4.37	1.06	4.15	-0.04	-0.08
EPS in Rs	—	1,36,50,811.60	4.02	-0.04	-0.08
Dividend Payout %	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	10	10	10	10
Reserves	3.69	4.78	8.93	8.89
Borrowings	1.87	4.58	4.88	5.84
Other Liabilities	7.17	8.55	8.48	11
Total Liabilities	23	28	33	36
Fixed Assets	3.50	4.62	5.07	4.45
CWIP	0.12	0.14	0.14	0.14
Investments	0.00	0.00	0.00	0.00
Other Assets	19	23	27	31
Total Assets	23	28	33	36

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	5.79	2.22	0.70	0.27
Cash from Investing Activity	-4.12	-0.94	-0.32	0.25
Cash from Financing Activity	0.67	-0.37	-0.16	0.45
Net Cash Flow	2.34	0.91	0.22	0.97

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
INVICTA	88.00	111 Cr	23.59	2.17	0.00	35.97	39.64	0.00
ASPIRA	66.96	69 Cr	28.56	9.47	0.00	16.62	13.17	13.75
NIDAN	18.95	26 Cr	13.44	0.39	0.00	3.32	6.57	2.69
GIANLIFE	8.89	9 Cr	—	0.48	0.00	-0.19	2.13	-0.22
CTLLAB	39.50	9 Cr	25.99	1.02	0.00	5.19	7.65	4.22
DLCL	17.50	8 Cr	25.36	0.76	0.00	4.53	3.40	2.92
DOLPHMED	2.61	4 Cr	—	0.39	0.00	-0.26	-0.12	-0.16

Overview

Detailed Summary

Gian Life Care Limited is primarily engaged in providing diagnostic and healthcare tests, operating major labs in Kanpur and Lucknow.

Established in 1995, Gian Pathology has evolved into a large diagnostic center under the leadership of Arun Kumar Gupta.

The company offers a wide range of approximately 1,344 diagnostic tests in multiple disciplines including molecular biology.

Gian Life Care expanded through an IPO, issuing over 1.4 million equity shares, raising Rs 3.11 Crore.

Plans are underway to set up more diagnostic labs across various regions, indicating growth ambitions.

Sector

Healthcare

Industry

Diagnostic Services

Market Cap

9 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

48.3

PEG Ratio

—

P/B Ratio

0.5

52W High

20.75

52W Low

8.28

Sales CAGR

-49.47%

-25.33%

-2.81%

10Y

—

Profit CAGR

-100.96%

-67.13%

-32.72%

10Y

—

ROE

TTM

-0.19%

10.44%

15.44%

10Y

—

ROCE

TTM

2.13%

14.60%

20.56%

10Y

—